BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26415906)

  • 1. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
    Gales AC; Reis AO; Jones RN
    J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colistin and Polymyxin B Susceptibility Testing for Carbapenem-Resistant and
    Chew KL; La MV; Lin RTP; Teo JWP
    J Clin Microbiol; 2017 Sep; 55(9):2609-2616. PubMed ID: 28592552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
    Gales AC; Jones RN; Sader HS
    Clin Microbiol Infect; 2006 Apr; 12(4):315-21. PubMed ID: 16524407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin.
    Sader HS; Rhomberg PR; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):412-4. PubMed ID: 23102558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
    Doymaz MZ; Karaaslan E
    Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
    [No Abstract]   [Full Text] [Related]  

  • 9. Antimicrobial activity of the novel polymyxin derivative NAB739 tested against Gram-negative pathogens.
    Vaara M; Sader HS; Rhomberg PR; Jones RN; Vaara T
    J Antimicrob Chemother; 2013 Mar; 68(3):636-9. PubMed ID: 23134658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of polymyxin B and the novel polymyxin analogue CB-182,804 against contemporary Gram-negative pathogens in New York City.
    Quale J; Shah N; Kelly P; Babu E; Backer M; Rosas-Garcia G; Salamera J; George A; Bratu S; Landman D
    Microb Drug Resist; 2012 Apr; 18(2):132-6. PubMed ID: 22196342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of susceptibility testing methods for polymyxin.
    Behera B; Mathur P; Das A; Kapil A; Gupta B; Bhoi S; Farooque K; Sharma V; Misra MC
    Int J Infect Dis; 2010 Jul; 14(7):e596-601. PubMed ID: 20045367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of susceptibility testing methods for determining the activity of colistin against Gram-negative bacilli of clinical origin.
    Haeili M; Kafshdouz M; Pishnian Z; Feizabadi MM; Martinez-Martinez L
    J Med Microbiol; 2019 Jan; 68(1):60-66. PubMed ID: 30422106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of disc diffusion, E-test, and broth microdilution methods for the determination of resistance to colistin, polymyxin B, and tigecycline in multi-resistant Acinetobacter baumannii isolates].
    Akin FE; Bayram A; Balci I
    Mikrobiyol Bul; 2010 Apr; 44(2):203-10. PubMed ID: 20549954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity of colistin in gram-negative bacteria.
    Tan TY; Ng SY
    Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
    Jones RN; Anderegg TR; Swenson JM;
    J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyxin B Etest
    Kulengowski B; Ribes JA; Burgess DS
    Clin Microbiol Infect; 2019 Jan; 25(1):92-95. PubMed ID: 29674129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manual Reading of Sensititre Broth Microdilution System Panels Improves Accuracy of Susceptibility Reporting for Polymyxin Antibiotics.
    Bellerose MM; Clark AE; Youn JH; Weingarten RA; Crooks CM; Dekker JP; Frank KM
    J Clin Microbiol; 2021 Aug; 59(9):e0033221. PubMed ID: 34165324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Sensititre Broth Microdilution Plate for determining the susceptibility of carbapenem-resistant Klebsiella pneumoniae to polymyxins.
    Richter SS; Karichu J; Otiso J; Van Heule H; Keller G; Cober E; Rojas LJ; Hujer AM; Hujer KM; Marshall S; Perez F; Rudin SD; Domitrovic TN; Kaye KS; Salata R; van Duin D; Bonomo RA
    Diagn Microbiol Infect Dis; 2018 May; 91(1):89-92. PubMed ID: 29456071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of different methods for testing polymyxin B: comparison of broth microdilution, agar dilution and MIC test strip in mcr-1 positive and negative Escherichia coli.
    Wang Y; Berglund B; Zhu Y; Luo Q; Xiao Y
    Lett Appl Microbiol; 2021 Aug; 73(2):197-205. PubMed ID: 33904164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.